LifeSci Inhibrx Inhibrx is a clinical-stage biotechnology company developing a pipeline of novel antibody therapies to treat oncology and orphan diseases Inhibrx in the News Visit WebsiteShare this...FacebookTwitterLinkedinEmail OTHER COMPANIES Back to All Companies
